Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01382082 · ClinicalTrials.gov registry record
Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy
A clinical trial, sponsored by University of Rochester NCORP Research Base.
- Active
- Registry status
- 1,432
- Enrollment target
NCT01382082: Active study, sponsored by University of Rochester NCORP Research Base.
NCT01382082 is a clinical trial that is active but no longer recruiting, run by University of Rochester NCORP Research Base. The registered enrollment target is 1,432 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01382082 is active but no longer recruiting, sponsored by University of Rochester NCORP Research Base.
- ACTIVE NOT RECRUITING
- Registry status
- 1,432 participants
- Enrollment target
Study Summary
Cognitive impairments in cancer patients represent an important clinical problem. Studies to date estimating prevalence of difficulties in memory, executive function, and attention deficits have been limited by small sample sizes and many have lacked healthy control groups. More information is needed on promising biomarkers and allelic variants that may help to determine the etiology of impairment, identify those most vulnerable to impairment, and develop interventions for these difficulties. This is a longitudinal observational study of cognitive function in breast cancer and lymphoma patients receiving chemotherapy to better understand the prevalence of cognitive difficulties (i.e., problems with memory, executive function, and attention) in these populations.
Primary Outcome
Change in Short-term visual memory will be assessed by the computerized Delayed Matching to Sample (DMS) task.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,432 participants |
| Start Date | 2011-07-14 |
| Est. Completion | 2026-12-31 |
What the registry record for NCT01382082 still lists
NCT01382082 is an observational study that tracks outcomes without assigning an intervention. Its 1,432 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01382082 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01382082 about?
NCT01382082 is a clinical study titled "Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy". Cognitive impairments in cancer patients represent an important clinical problem. Studies to date estimating prevalence of difficulties in memory, executive function, and attention deficits have been limited by small sample sizes and many have lacked healthy control groups. More information is neede...
What is the current status of trial NCT01382082?
This trial is currently active not recruiting. The enrollment target is 1,432 participants. The study started on 2011-07-14. Estimated completion is 2026-12-31.
Who is sponsoring clinical trial NCT01382082?
This trial is sponsored by University of Rochester NCORP Research Base, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04754022 · 1,440 participants · NA
Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery
- NCT04989790 · 1,440 participants · NA
Clinical Effectiveness of the "PICU Up!" Multifaceted Early Mobility Intervention for Critically Ill Children
- NCT06122246 · 1,440 participants · NA
PRESSURE CHECK: Find Your Path to Better Health
- NCT06324318 · 1,440 participants · Phase 2
Parenting in 2 Worlds Multisite Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI